HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo's Turnaround Tools: 'National Brand,' Novel NRTs, CBD And Natural Products, Sponsoring OTC Switches

Executive Summary

Following investor day conference, market analysts gave Perrigo points for an ambitious three-year plan while also noting the degree of difficulty it faces in succeeding. Other changes planned to stem slump sales and earnings slump include potentially getting into CBD supplement space and getting back into VMS manufacturing after leaving the sector in one of several moves since 2015 intended to help drive net income and improve its margin.

Advertisement

Related Content

States Could Take Bloom Off Growth Of CBD Supplement, Food Market
IRS Notice Pushes Perrigo's Potential Tax Debt From Move To Ireland Close To $3bn
Wider Options In FDA's NRT Clinical Trial Guidance, Approval Path Still Narrow
Perrigo's CFO Brings History With CEO; Vitamin Shoppe Looks For Another CFO
Perrigo Lights Smoking Cessation For Growth With Turnaround Woes 'Fixable'
Perrigo's OTC Core Could Expand To Include National Brands
Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo
GSK Aims Flonase Sensimist To Counter Generic Nasal Allergy Competition
Perrigo Out From Under VMS Weight As IVC Lifts Private Label Profile

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS148805

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel